MALCOLM JAN 4

What Happened Malcolm Jan, a non-employee director of United Therapeutics Corporation (UTHR), was granted two restricted stock unit (RSU) awards on 2026-07-22 totaling 1,570 RSUs (380 RSUs + 1,190 RSUs). The filing reports an acquisition price of $0.00 for each award — typical for RSU grants, which are derivative awards that convert to shares upon vesting. The Form 4 was filed on 2026-07-23.

Key Details

• Transaction date: 2026-07-22; Form 4 filed: 2026-07-23 (timely).
• Award details: 380 RSUs and 1,190 RSUs; aggregate = 1,570 RSUs; price per unit reported $0.00.
• Nature of award: Derivative RSUs (transaction code A — grant/award).
• Shares owned after transaction: Not disclosed in this filing.
• Footnotes:
  • Each RSU represents the right to receive one share upon vesting (F1).
  • These are annual non-employee director awards (F2).
  • Vesting occurs on the earlier of (a) one-year anniversary of grant or (b) the next Annual Meeting of Shareholders (anticipated June 25, 2027) (F3).
  • RSUs have no expiration date (F4).

Context RSU grants to non-employee directors are a common form of compensation and do not represent an immediate purchase or sale of stock. These awards only convert into actual shares if and when they vest according to the stated schedule; they are not an indication of immediate buying or selling activity by the director.